Phase II Study of FOLFIRINOX Chemotherapy for Treatment of Advanced Gastric, Gastro-oesophageal Junction, and Oesophageal Tumours
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Trastuzumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 26 Jan 2017 Planned End Date changed from 1 Mar 2018 to 28 Feb 2021.
- 18 Mar 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018 as reported by ClinicalTrials.gov record.
- 18 Mar 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018 as reported by ClinicalTrials.gov record.